08 November 2023
08 November 2023
The new incentives to improve access to medication across Europe are seen as innovation-stifling measures by the industry.
Following these results, Takeda will initiate Phase III trials of TAK-279 in psoriatic arthritis and plaque psoriasis.
OTTAVA robotic surgical system from Johnson & Johnson MedTech is to be submitted for an investigational device exemption application with the FDA.
Financial and exclusivity incentives are needed to retain Europe’s position across the globe, as industry battles for a better legislation.
Larsucosterol failed to meet the primary endpoint but showed a significant trend in reducing mortality in patients with alcohol-associated hepatitis.
A Phase II trial into a drug designed to treat severe alcohol dependence was able to halve alcohol intake among its 154 participants in a multi-centre double blind trial.
Real-world data has been used in the NHS Galleri trial as a method to improve improving the diversity of patients involved.
Medidata Rave EDC will be combined with EDETEK CONFORM to carry out the assessment, cleaning, and calibration of data.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
